Biosimilars In Oncology

Oncology is the study of cancer. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. An oncologist may also be called a cancer specialist. The field of oncology has 3 major areas based on treatments: medical oncology, radiation oncology, and surgical oncology. The primary purpose of biosimilars is to reduce the healthcare costs associated with the use of biologics and thereby increase access to healthcare. Unlike small molecule generics, the bioequivalence approach is not considered appropriate for the approval of biosimilars.

 

    Related Conference of Biosimilars In Oncology

    October 24-25, 2024

    8th International Conference on Protein Engineering

    Zurich, Switzerland

    Biosimilars In Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in